- Previous Close
12.98 - Open
12.92 - Bid 12.96 x 100
- Ask 13.22 x 100
- Day's Range
12.52 - 13.12 - 52 Week Range
3.03 - 18.41 - Volume
74,693 - Avg. Volume
292,748 - Market Cap (intraday)
351.846M - Beta (5Y Monthly) 1.37
- PE Ratio (TTM)
-- - EPS (TTM)
-0.15 - Earnings Date Mar 18, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
27.67
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
www.etonpharma.com31
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: ETON
View More
Performance Overview: ETON
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ETON
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ETON
View MoreValuation Measures
Market Cap
347.82M
Enterprise Value
362.81M
Trailing P/E
--
Forward P/E
30.86
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.61
Price/Book (mrq)
14.24
Enterprise Value/Revenue
9.30
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-9.80%
Return on Assets (ttm)
-2.53%
Return on Equity (ttm)
-19.16%
Revenue (ttm)
39.01M
Net Income Avi to Common (ttm)
-3.82M
Diluted EPS (ttm)
-0.15
Balance Sheet and Cash Flow
Total Cash (mrq)
14.94M
Total Debt/Equity (mrq)
122.79%
Levered Free Cash Flow (ttm)
-18.78M